Altimmune, Inc. (ALT) vs Crescent Biopharma, Inc. (CBIO)
- Altimmune, Inc. ALT 2.20 −6.78%
- Crescent Biopharma, Inc. CBIO 11.84 −5.13%
Altimmune, Inc. and Crescent Biopharma, Inc. are both Biotechnology companies. Altimmune, Inc. and Crescent Biopharma, Inc. are of similar size ($463.6M and $459.1M). Altimmune, Inc. grew revenue faster over the last twelve months: 130.0% against −45.1%. Across the 15 metrics below, Altimmune, Inc. leads on 8 and Crescent Biopharma, Inc. on 7.
Valuation
Profitability
| Metric | ALT | CBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 19.72% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (28.87%) | (112.14%) | (56.36%) |
| Return on assets | (25.58%) | (97.08%) | (48.04%) |
| Return on invested capital | (34.30%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack